While weight loss is achievable, weight maintenance remains a lifetime challenge ( A new generation of anti-obesity medications (AOMs) has revolutionized the way obesity is treated, enabling most patients to lose 10-20% of their body weight
Tirzepatide combines GLP-1 and GIP receptor agonists
Improved glycemic control appears within the first few weeks of treatment, often before significant weight loss occurs
Long-Term Heart Protection Confirmed The researchers examined results from 11 major cardiovascular outcome trials that followed patients for at least one year
Together, this synergistic blend is being explored in preclinical research for its ability to accelerate wound healing, mitigate inflammation, and enhance recovery in models of soft tissue injury, nerve damage, and musculoskeletal trauma
Molecular weight approximately 390.35 Da